期刊文献+

雄黄纳米微粒对人白血病细胞株HL-60的诱导分化作用 被引量:19

Differentiation of HL-60 cells induced by realgar nano-particles
下载PDF
导出
摘要 目的:探讨雄黄(As4S4)纳米微粒对于人急性早幼粒白血病细胞HL-60的抑制增殖和诱导分化作用。方法:采用MTT法观察低浓度雄黄对HL-60细胞增殖的影响,Wright-Giemsa染色观察细胞形态,硝基四氮唑蓝(NBT)还原反应和流式细胞术抗原检测等鉴定细胞的分化。结果:细胞经雄黄处理后呈现明显的分化形态。经0.25-1.0μmol·L^-1雄黄作用24h后,NBT阳性率升高。用0.50μmol·L^-1雄黄处理48h,细胞表面分化抗原CD11b表达升高,细胞周期阻滞于G期。结论:低浓度雄黄对HL-60细胞具有诱导分化作用。 Objective. To investigate the proliferation inhibition and the differentiation effects of realgar (As4S4) nano-particles on human acute myeloid leukemia cell line HL-60. Method: Cell viability was determined by MTT and PI-stained cell cycle assays. The realgar induced morphological changes on cells were examined after Wright-Giemsa staining. The cell differentiation was evaluated with NBT and specific cell surface antigen (CDllb and CD14) expression assays. Result: HL-60 cells exhibited obvious morphological features of differentiation after the realgar treatment. A 24 h incubation of the cells with 0.25-1.0μmol·L^-1 realgar caused a great increase in NBT reduction ability. The expressious of CD11b and CD14 were augmented in cells treated with 0.50μmol·L^-1 realgar for 48 h, and cell cycles were arrested in G1 phase. Conclusion: Low dose realgar induces differentiation in human acute myeloid leukemia cell line HL-60.
出处 《中国中药杂志》 CAS CSCD 北大核心 2006年第16期1343-1346,共4页 China Journal of Chinese Materia Medica
基金 国家自然科学基金资助项目(2027100520571006)
关键词 雄黄 HL-60 细胞分化 纳米微粒 白血病 realgar HL-60 cell differentiation nanoparticles leukemia
  • 相关文献

参考文献4

二级参考文献59

  • 1史曦凯,张翼军,裴莉,张红宾.以米托蒽醌为主的化疗方案治疗成人急性白血病疗效分析[J].第三军医大学学报,2003,25(13):1126-1126. 被引量:3
  • 2向阳,黄世林,郭爱霞,白月辉,韩福英,季梅琴,颜晋安,任君.复方青黛片为主治疗急性早幼粒细胞白血病60例[J].解放军医学杂志,1995,20(3):227-229. 被引量:3
  • 3ZHANGTL, GAOYX, LUJF, et al. Arsenite, arsenate and vonadate affect buman erythrocyte membrane. J Inorg Biochem,2000,79:195.
  • 4Dai J, Weinberg R S, Waxnan S, et al. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood,1999,93:268.
  • 5CAI X, SHEN Y L, ZHU Q, et al. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leulcemia, 2000,14(2) :262.
  • 6Slack J L, Rusiniak M E. Current issues in the management of acute promyelocytic leukemia. Ann Hematol, 2000,79(5) :227.
  • 7LU D P, QIU J Y, JIANG B, et al. Effective treatment of acute promyelocytic leukmia(APL) with tetra-arsenic tetra-sulfide (As4S4),a monoinstitutional study (abstract). Blood,1999,94(10)Suppl 1:698a.
  • 8WANG Z Y. Arsenic compounds as anticancer agents. Cancer Chemother Pharmacol, 2001,48 Suppl 1:S72.
  • 9MarczenkoZ.元素的分光光度测定[M].北京:地质出版社,1976.122.
  • 10CHEN GQ, ZHUJ, SHI X G, et al. In vitro studies on cellular and molecular mechmisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RARα/PML proteins.Blood, 1996,88:1052.

共引文献58

同被引文献289

引证文献19

二级引证文献148

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部